Search
for
Sort by
Research 301–330 of 657
- Research gaps in medical treatment of transgender/nonbinary people
- Cyclosporine-A-Induced Intracranial Thrombotic Complications: Systematic Review and Cases Report
- The Rare Occurrence of a Left Atrial Thrombus in a Dog
- WARFARIN-INDUCED ALOPECIA: A RARE CASE REPORT
- Symptomatology of Long COVID Associated with Inherited and Acquired Thrombophilic Conditions: A Systematic Review
- Short‐Term, Low‐Dose Spironolactone for Treatment of Hyperandrogenic Symptoms of Polycystic Ovary Syndrome—A Systematic Review
- Rationale and design of the GLADE study: a randomized, multicenter, double-blind, placebo-controlled trial evaluating the safety and efficacy of gestrinone subdermal bioabsorbable pellet in endometriosis-related pelvic pain
- Hormones and COVID-19
- A case of severe autoimmune hemolytic anemia after a receipt of a first dose of SARS‐CoV‐2 vaccine
- Off‐Label Use of Topical Ruxolitinib in Dermatology: A Systematic Literature Review and Current Perspectives
- METYRAPONE AS A BRIDGING THERAPY IN FLORID CUSHING’S DISEASE PATIENT PRIOR TO PITUITARY ADENOMECTOMY
- Inflammasome Proteins as Biomarkers of Injury and Disease
- Evidence based medicine: a movement in crisis?
- Understanding, recognizing, and managing toxicities of targeted anticancer therapies
- COVID‐19 and cutaneous manifestations: A review of the published literature
- Post-COVID-19 Syndrome Mechanisms, Prevention and Management
- Diverse origins of fibrinolytic enzymes: A comprehensive review
- The immune response to COVID‐19: Does sex matter?
- Cardiovascular Risk Associated With Gender Affirming Hormone Therapy in Transgender Population
- Update on the combination of myo-inositol/d-chiro-inositol for the treatment of polycystic ovary syndrome
- Hair Loss Is a Potential Side Effect of Novel Oral Anticoagulants – Findings From the Dresden Noac Registry (NCT01588119)
- Polycystic Ovary Syndrome and the Potential for Nanomaterial-Based Drug Delivery in Therapy of This Disease
- Ultra-low dose estradiol and dydrogesterone for the treatment of menopausal symptoms in a pooled, multi-ethnic population
- Vitamin E-induced coagulopathy in a young patient: a case report
- A brief review of the literature on the malignant ureteral obstruction
- Harm reduction measures in a recreational gym user with anabolic androgenic steroid dependence: a case report in the context of current best clinical practice
- Oral contraceptive pill (OCP) treatment alters the gene expression of intercellular adhesion molecule-1 (ICAM-1), tumor necrosis factor-α (TNF-α), monocyte chemoattractant protein-1 (MCP-1) and plasminogen activator inhibitor-1 (PAI-1) in polycystic ovary syndrome (PCOS) women compared to drug-naive PCOS women
- Post severe COVID-19 infection lung damages study. The experience of early three months multidisciplinary follow-up
- Post-Acute COVID-19 Sequelae – ‘COVID Long Hauler’
- Anti-androgen therapy in polyendocrine metabolic ovary syndrome (PMOS, formerly PCOS): efficacy, safety, and phenotype-oriented clinical decision-making